MedPath

Clinical decision making in patients with cataract and Fuchs* endothelial dystrophy (FED): validation of in vivo confocal microscopy backscatter and OCT as a predictive measurements to decide to perform a phaco- or triple procedure.

Completed
Conditions
Cataract and FED
10015917
Registration Number
NL-OMON42593
Lead Sponsor
Oogziekenhuis Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

- Age >= 18 years.
- Informed consent.
- FED stage = 2.
- Cataract requiring surgery.
- Visual acuity (VA) < 0.7.

Exclusion Criteria

- Indication for triple procedure.
- History of other ocular disorders affecting VA.
- History of intra-ocular, corneal or refractive surgery.
- Severe nystagmus.
- Corneal opacity in the pre-pupillary region not related to FED.
- Corneal neovascularization > 1 quadrant.
- Amblyopia.
- Expected VA after surgery < 0.6.
- Fellow eye already included in this study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Preoperative corneal backscatter; postoperative<br /><br>number of patients requiring PLK (y/n).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Preoperative:<br /><br>- LOCS III classification of cataract.<br /><br><br /><br>Preoperative and one month postoperative:<br /><br>- OCT grayscale of the corneal stroma.<br /><br>- Best corrected visual acuity (BCVA; ETDRS).<br /><br>- Pachymetry (Tomey).<br /><br>- Contrast sensitivity (CS; Pelli-Robson).<br /><br>- Straylight (C-Quant).<br /><br>- VFQ-25 questionnaire.<br /><br><br /><br>Perioperative:<br /><br>- Phaco time and energy.</p><br>
© Copyright 2025. All Rights Reserved by MedPath